ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2216

Expanding Reproductive Health Assessments in Rheumatic Diseases: A Comparative Analysis of Demographic and Disease-Specific Factors

Krista Topalsky1, Chelsea Guan2, Lindsay Frumker3, Dana Nachawati2, Areeb Tiwana4, Meghan Gump2, Omer Pamuk5 and Marina Magrey6, 1University Hospitals, Shaker Heights, OH, 2University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH, 3University hospitals Cleveland medical center, Highland Heights, OH, 4Canton Medical Education Foundation, Canton, OH, 5University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH, 6Case Western Reserve University School of Medicine/University Hospitals Cleveland, Richfield, OH

Meeting: ACR Convergence 2025

Keywords: education, patient, health behaviors, pregnancy, Surveys, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2195–2226) Reproductive Issues in Rheumatic Disorders Posters

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Building on our 2024 ACR study (Topalsky et al.) that described broad knowledge gaps and interest in reproductive health education among women with rheumatic diseases, we designed a follow-up study to assess whether these needs vary across clinical and demographic subgroups. This study aimed to explore whether disease type, time since diagnosis, or age significantly influence sexual and reproductive health (SRH) concerns amongst our patients.

Methods: In this follow-up study, a revised survey was sent to our female patients aged 18-45 years with autoimmune rheumatic diseases seen in the Rheumatology Department at our institution. We developed a mixed-format questionnaire expanding on the 2024 survey to further assess demographic, clinical, and attitudinal data. Subjects were identified using Slicer Dicer, a data exploration tool in the EPIC EMR that allows for customized searches on large patient populations. Surveys were sent and patient responses collected through REDCap, a secure web application for building and managing online surveys and databases. We conducted chi-square analyses comparing outcomes across subgroups (disease type, time since diagnosis, age group) to identify any differential needs. The study received IRB approval at our institution.

Results: 200 patients received an online survey, of which 61 replied, yielding a 30.5% response rate. Respondents were predominantly middle-aged white patients with a range of rheumatologic diagnoses, most of whom felt their disease was stable (Figure 1). About half reported ever receiving pregnancy-related information and understanding of pregnancy risks varied, with a large portion feeling only somewhat or not informed (Figure 2). Interest in targeted reproductive-health education was high across all subgroups, particularly around fertility and conception as well as managing parenthood with a chronic illness (Figure 3).Subgroup analyses revealed no significant differences by disease type, diagnosis duration, or age in disease control, contraception use, pregnancy concerns, information receipt, risk understanding, or interest in educational sessions (all p > 0.05), suggesting that reproductive‐health needs are uniformly shared across all patient subgroups.

Conclusion: While our 2024 abstract described widespread informational gaps and a strong preference for online education, this follow-up with novel subgroup analysis reveals that these gaps and needs are uniformly experienced across all patient groups. This supports the development of universally accessible reproductive health education for rheumatology patients. These insights go beyond earlier descriptive findings and directly inform the design of inclusive educational interventions.

Supporting image 1Figure 1. Demographic and Clinical Characteristics of Respondents

Supporting image 2Figure 2. Unmet Educational Needs: Information Sources and Risk Understanding

Supporting image 3Figure 3. Interest in Reproductive Health Education Topics


Disclosures: K. Topalsky: None; C. Guan: None; L. Frumker: None; D. Nachawati: None; A. Tiwana: None; M. Gump: None; O. Pamuk: None; M. Magrey: AbbVie, 2, 5, Amgen, 5, BMS, 2, 5, Eli Lilly, 2, Novartis, 2, Pfizer, 2, UCB, 2, 5.

To cite this abstract in AMA style:

Topalsky K, Guan C, Frumker L, Nachawati D, Tiwana A, Gump M, Pamuk O, Magrey M. Expanding Reproductive Health Assessments in Rheumatic Diseases: A Comparative Analysis of Demographic and Disease-Specific Factors [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/expanding-reproductive-health-assessments-in-rheumatic-diseases-a-comparative-analysis-of-demographic-and-disease-specific-factors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expanding-reproductive-health-assessments-in-rheumatic-diseases-a-comparative-analysis-of-demographic-and-disease-specific-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology